Abstract
Breast cancer treatment encompasses various therapeutic modalities, including surgery, radiotherapy, and chemotherapy. Breast-conserving surgery has been an integral part of breast cancer management. However, radiotherapy, an important component of breast cancer management, can lead to complications, particularly fibrosis, affecting reconstructive surgery outcomes. We conducted an in vivo study using 48 female Wistar Albino rats, employing segmental mastectomy and radiotherapy to simulate post-mastectomy conditions. The rats were divided into six groups: control, mastectomy, mastectomy + radiotherapy, mastectomy + platelet-rich plasma (PRP) + radiotherapy, mastectomy + infliximab + radiotherapy, and mastectomy + infliximab + PRP + radiotherapy. Edema, hyperemia, inflammation, and fibrosis were assessed as indicators of tissue response. Histopathological analysis revealed that mastectomy + infliximab and mastectomy + infliximab + PRP groups showed significant reductions in fibrosis compared to other groups. Edema, hyperemia, and inflammation were also less severe in these groups compared to the control group. Radiotherapy-induced fibrosis is a major concern in breast reconstruction. Our study suggests that local PRP application and systemic infliximab administration, either alone or in combination, could mitigate the adverse effects of radiotherapy. This approach has the potential to improve reconstructive outcomes in patients undergoing or having the possibility to undergo radiotherapy. This is the first study showing the effectiveness of infliximab and PRP combination on wound healing. The provided experimental rat model might offer guidance for further research. This study provides insights into optimizing outcomes in reconstructive breast surgery, paving the way for further research and clinical studies.
Similar content being viewed by others
Data availability
All relevant data are included in the manuscript.
References
Alderman A, Gutowski K, Ahuja A, Gray D (2014) ASPS clinical practice guideline summary on breast reconstruction with expanders and implants. Plast Reconstr Surg 134:648e–655e. https://doi.org/10.1097/PRS.0000000000000541
Almadani YH, Vorstenbosch J, Davison PG, Murphy AM (2021) Wound healing: a comprehensive review. Semin Plast Surg 35:141–144. https://doi.org/10.1055/s-0041-1731791
Almahariq MF, Quinn TJ, Siddiqui Z et al (2020) Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer. Radiother Oncol 142:186–194. https://doi.org/10.1016/j.radonc.2019.09.018
Alves R, Grimalt R (2018) A review of platelet-rich plasma: history, biology, mechanism of action, and classification. Skin Appendage Disord 4:18–24. https://doi.org/10.1159/000477353
Anavekar NS, Rozen WM, Le Roux CM, Ashton MW (2011) Achieving autologous breast reconstruction for breast cancer patients in the setting of post-mastectomy radiotherapy. J Cancer Surviv 5:1–7. https://doi.org/10.1007/s11764-010-0155-5
Braun HJ, Wasterlain AS, Dragoo JL (2013) The use of PRP in ligament and meniscal healing. Sports Med Arthrosc 21:206–212. https://doi.org/10.1097/JSA.0000000000000005
Dhillon RS, Schwarz EM, Maloney MD (2012) Platelet-rich plasma therapy—future or trend? Arthritis Res Ther 14:219. https://doi.org/10.1186/ar3914
El-Sharouny SH, El Enein Rizk AA, Rashed LA et al (2019) Analysis of the therapeutic role of platelet-rich plasma against cisplatin-induced hepatotoxicity in rats: controversy between oxidative and apoptotic markers. Eur J Anat 23:201–213
Evin N, Tosun Z, Aktan TM et al (2021) Effects of adipose-derived stem cells and platelet-rich plasma for prevention of alopecia and other skin complications of radiotherapy. Ann Plast Surg 86:588–597. https://doi.org/10.1097/SAP.0000000000002573
Farghali HA, AbdElKader NA, AbuBakr HO et al (2019) Antimicrobial action of autologous platelet-rich plasma on MRSA-infected skin wounds in dogs. Sci Rep 9:12722. https://doi.org/10.1038/s41598-019-48657-5
Farrag TY, Lehar M, Verhaegen P et al (2007) Effect of platelet rich plasma and fibrin sealant on facial nerve regeneration in a rat model. Laryngoscope 117:157–165. https://doi.org/10.1097/01.mlg.0000249726.98801.77
Faul F, Erdfelder E, Lang A-G, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175–191. https://doi.org/10.3758/BF03193146
Goessler UR, Bugert P, Kassner S et al (2010) In vitro analysis of radiation-induced dermal wounds. Otolaryngol Neck Surg 142:845–850. https://doi.org/10.1016/j.otohns.2010.01.033
Kim JH, Kolozsvary AJJ, Jenrow KA, Brown SL (2013) Mechanisms of radiation-induced skin injury and implications for future clinical trials. Int J Radiat Biol 89:311–318. https://doi.org/10.3109/09553002.2013.765055
Lei S, Zheng R, Zhang S et al (2021) Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020. Cancer Commun 41:1183–1194. https://doi.org/10.1002/cac2.12207
Li ZJ, Choi H-I, Choi D-K et al (2012) Autologous platelet-rich plasma: a potential therapeutic tool for promoting hair growth. Dermatol Surg 38:1040–1046. https://doi.org/10.1111/j.1524-4725.2012.02394.x
Litière S, Werutsky G, Fentiman IS et al (2012) Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol 13:412–419. https://doi.org/10.1016/S1470-2045(12)70042-6
Maughan KL, Lutterbie MA, Ham PS (2010) Treatment of breast cancer. Am Fam Physician 81:1339–1346
Ribuffo D, Atzeni M, Guerra M et al (2013) Treatment of irradiated expanders: protective lipofilling allows immediate prosthetic breast reconstruction in the setting of postoperative radiotherapy. Aesthetic Plast Surg 37:1146–1152. https://doi.org/10.1007/s00266-013-0221-2
Salazar-Álvarez AE, Riera-del-Moral LF, García-Arranz M et al (2014) Use of platelet-rich plasma in the healing of chronic ulcers of the lower extremity. Actas Dermosifiliogr 105:597–604. https://doi.org/10.1016/j.ad.2013.12.011
Sheng X, Zhou Y, Wang H et al (2019) Establishment and characterization of a radiation-induced dermatitis rat model. J Cell Mol Med 23:3178–3189. https://doi.org/10.1111/jcmm.14174
Suthar M, Gupta S, Bukhari S, Ponemone V (2017) Treatment of chronic non-healing ulcers using autologous platelet rich plasma: a case series. J Biomed Sci 24:16. https://doi.org/10.1186/s12929-017-0324-1
Tasdemir C, Samdanci ET, Turtay MG et al (2011) Histopathological effects of fibrin glue on penile fracture in a rat model. Clin Investig Med 34:336. https://doi.org/10.25011/cim.v34i6.15893
Vos ACW, Wildenberg ME, Arijs I et al (2012) Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro. Inflamm Bowel Dis 18:401–408. https://doi.org/10.1002/ibd.21818
Vrieling C, Collette L, Fourquet A et al (2000) The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC ‘boost vs. no boost’ trial. Radiother Oncol 55:219–232. https://doi.org/10.1016/S0167-8140(00)00210-3
Willrich MAV, Murray DL, Snyder MR (2015) Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases. Transl Res 165:270–282. https://doi.org/10.1016/j.trsl.2014.09.006
Yun JH, Diaz R, Orman AG (2018) Breast reconstruction and radiation therapy. Cancer Control 25:107327481879548. https://doi.org/10.1177/1073274818795489
Funding
No funding was received for the research presented in this manuscript.
Author information
Authors and Affiliations
Contributions
Study conception and design: SB and ÜHİ; data collection: SB, MG, ZAİ, BD and SU analysis and interpretation of results: SB, MG, AÖ, ZAİ, BD and ÜHİ draft manuscript preparation: SB, MG, AÖ, SU, and ÜHİ. All authors reviewed the results and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
There are no competing interests or conflicts of interest to disclose regarding this study.
Ethics approval
Ethical approval for this research was obtained from the Van Yüzüncü Yıl University Animal Experiments Local Ethics Committee of Van Yüzüncü Yıl University under protocol number 2021/10-12. All experimental procedures were conducted in strict adherence to ethical guidelines.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Binici, S., Güven, M., Özdemir, A. et al. Addressing radiotherapy-induced fibrosis: the potential of platelet-rich plasma and infliximab for improved breast cancer management. Histochem Cell Biol 161, 381–389 (2024). https://doi.org/10.1007/s00418-024-02267-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00418-024-02267-z